We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Uniphar plc (UPR) ORD EUR0.08

Sell:218.00p Buy:222.00p 0 Change: 4.00p (1.79%)
FTSE AIM 100:0.02%
Market closed |  Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:218.00p
Buy:222.00p
Change: 4.00p (1.79%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:218.00p
Buy:222.00p
Change: 4.00p (1.79%)
Market closed |  Prices as at close on 19 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Share news, reports & tips

  • Uniphar posts robust set of full-year results

    27 February 2024 09:35

    (Sharecast News) - Healthcare services company Uniphar reported a robust set of preliminary results on Tuesday, with EBITDA rising 17.7%, as it achieved a return on capital employed of 15.2% and maintained...

  • Uniphar ends year in line with expectations

    30 January 2024 12:33

    (Sharecast News) - Pharmaceutical and medical technology service company Uniphar said in an update on Tuesday that its performance in 2023 met its own expectations in terms of gross profit and EBITDA, while...

  • Uniphar gross profit jumps in first half

    14 September 2023 12:27

    (Sharecast News) - Healthcare services company Uniphar reported gross profit growth of 28.6% in its first half on Thursday, of which 5.5% was organic, representing progress across all divisions.

  • Uniphar maintains expectations amid strong trading

    11 May 2023 12:19

    (Sharecast News) - Uniphar reported strong performance over the last year in an update on Thursday, reporting further progress towards its financial and strategic objectives.

  • Uniphar upbeat on strong full-year performance

    28 February 2023 16:14

    (Sharecast News) - Healthcare service provider Uniphar reported a strong full-year performance on Tuesday, with EBITDA growth of 13.4%, return on capital employed of 17.3%, and year-end leverage of 1.0x.

  • Irish regulator blocks Uniphar takeover of Navi

    16 December 2022 16:21

    (Sharecast News) - Uniphar announced on Friday that Ireland's Competition and Consumer Protection Commission (CCPC) had not cleared the proposed acquisition of the Irish-based pharmacy services firm...

  • Uniphar buys BModesto for initial EUR 51m

    21 November 2022 10:09

    (Sharecast News) - Uniphar announced the €51m acquisition of Netherlands-based healthcare services business BModesto Group on Monday, which works in pharmaceutical and healthcare products access in the...

  • Uniphar buys healthcare consultancy Inspired Health

    4 October 2022 09:30

    (Sharecast News) - Uniphar announced the acquisition of US-based healthcare insights and intelligence consultancy Inspired Health on Tuesday.

  • Uniphar ends first half in line with expectations

    26 July 2022 15:38

    (Sharecast News) - Healthcare services company Uniphar said in an update on Tuesday that it performed in line with its expectations in the first half, at both a gross profit and EBITDA level, while...

  • Uniphar posts strong profit growth for 2021

    1 March 2022 11:37

    (Sharecast News) - Healthcare service provider Uniphar reported a 26.3% improvement in gross profit in its preliminary results on Tuesday to €274.5m (£228.54m), or 8.5% on an organic basis.

  • Uniphar ends year with lower-than-expected debt levels

    26 January 2022 15:37

    (Sharecast News) - Healthcare services company Uniphar said in a trading update on Wednesday that it performed in line with its own expectations for 2021, at both a gross profit and EBITDA level, with strong...

  • Uniphar makes three pharma sector acquisitions

    23 December 2021 10:00

    (Sharecast News) - Uniphar announced the acquisitions of UK-based brand commercialisation and pharmaceutical marketing agency E4H, UK-based pharmaceutical distributor Devonshire Healthcare Services, and...

Company announcements Announcements


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2024. All rights reserved.

Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.